QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

KLRA

QT—Kailera Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
19.90
+0.77+4.03%
OverviewShort InterestFilings
KLRAKailera Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
19.90+4.03%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand129.57M
Perf Week1.84%
Market Cap2.48BForward P/E-EPS next Y-Insider Trans15.82%Shs Float-Perf Month1.43%
Enterprise Value-PEG-EPS next Q-Inst Own-Short Float-Perf Quarter-
Income-P/S-EPS this Y-Inst Trans-Short Ratio-Perf Half Y-
Sales-P/B-EPS next Y-ROA-Short Interest-Perf YTD-
Book/sh-P/C-EPS next 5Y-ROE-52W High-Perf Year-
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-52W Low-Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin-Volatility5.25% 4.97%Perf 5Y-
Dividend TTM-EV/Sales-EPS Y/Y TTM-Oper. Margin-ATR (14)1.61Perf 10Y-
Dividend Ex-Date-Quick Ratio-Sales Y/Y TTM-Profit Margin-RSI (14)44.07Recom-
Dividend Gr. 3/5Y-Current Ratio-EPS Q/Q-SMA20-3.93%Beta1.14Target Price42.00
Payout-Debt/Eq-Sales Q/Q-SMA50-Rel Volume-Prev Close19.13
Employees145LT Debt/Eq-EarningsAug 25SMA200-Avg Volume-Price19.90
IPO DateApr 17, 2026Option/ShortNo / YesEPS/Sales Surpr.-470867.74% -Net Debt/EBITDA-Volume4,355,830Change4.03%
Analyst Ratings
DateActionAnalystRatingTarget
May-12-26InitiatedLeerinkOutperform$36
May-12-26InitiatedJefferiesBuy$48
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Insider Trading Volume
$22.63$20.68$18.73$16.77$14.82● Close Price0.00M81.69M163.38M245.06M326.75MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Renaud Ronald C JRCEO & PresidentJun 09 '26Option Exercise5.2576,188399,988817,826Jun 11 12:00 AM
RTW INVESTMENTS, LP10% OwnerApr 20 '26Buy16.00500,0008,000,00010,776,820Apr 22 12:00 AM
Bain Capital Life Sciences Investors, LLC10% OwnerApr 20 '26Buy16.001,562,50025,000,00022,583,268Apr 20 12:00 AM
BAIN CAPITAL INVESTORS LLC10% OwnerApr 20 '26Buy16.008,398,438134,375,00826,255,581Apr 20 12:00 AM
Koppel Adamdirector, 10 percent owner:Apr 20 '26Buy16.001,562,50025,000,00022,583,268Apr 20 12:00 AM
Kaplan Andrew T.director, 10 percent owner:Apr 20 '26Buy16.008,398,438134,375,00826,255,581Apr 20 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR